Clinical Trial

The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2026 (before its estimated April 17, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction
Trial Details
NCT Number NCT07456488
Lead Sponsor Liaquat National Hospital & Medical College
Conditions Focus on Axial Length
Enrollment 60 participants
Start Date 2025-07-13
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-06